Evidence map›Paper›PMID 38721279›Full record

ArticleMolecular therapy. Nucleic acids2024

Expanding RNA editing toolkit using an IDR-based strategy.

Minghui Di, Junjun Lv, Zhengyu Jing, Yijie Yang, Kunlun Yan, Jianguo Wu, Jianyang Ge, Simone Rauch, Bryan C Dickinson, Tian Chi

Abstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A Manual for Genome and Transcriptome Engineering.IEEE reviews in biomedical engineering · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Minghui DiSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Junjun LvSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Zhengyu JingSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Yijie YangSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Kunlun YanSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Jianguo WuSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Jianyang GeSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Simone RauchDepartment of Chemistry, University of Chicago, Chicago, IL 60637, USA.
Bryan C DickinsonDepartment of Chemistry, University of Chicago, Chicago, IL 60637, USA.
Tian ChiSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.

Funding

Rapid selection approaches to understand and reprogram proteins and peptidesR35GM119840 · NIGMS · UNIVERSITY OF CHICAGO · PI Bryan Dickinson · 2016 to 2026
$4.8M
NIGMS NIH HHS R35 GM119840
6 · The paper itself

Abstract

RNA base editors should ideally be free of immunogenicity, compact, efficient, and specific, which has not been achieved for C > U editing. Here we first describe a compact C > U editor entirely of human origin, created by fusing the human C > U editing enzyme RESCUE-S to Cas inspired RNA targeting system (CIRTS), a tiny, human-originated programmable RNA-binding domain. This editor, CIRTS-RESCUEv1 (V1), was inefficient. Remarkably, a short histidine-rich domain (HRD), which is derived from the internal disordered region (IDR) in the human CYCT1, a protein capable of liquid-liquid phase separation (LLPS), enhanced V1 editing at on-targets as well as off-targets, the latter effect being minor. The V1-HRD fusion protein formed puncta characteristic of LLPS, and various other IDRs (but not an LLPS-impaired mutant) could replace HRD to effectively induce puncta and potentiate V1, suggesting that the diverse domains acted via a common, LLPS-based mechanism. Importantly, the HRD fusion strategy was applicable to various other types of C > U RNA editors. Our study expands the RNA editing toolbox and showcases a general method for stimulating C > U RNA base editors.

Indexed as

CIRTScompacthuman originIDRimmunogenicityLLPSMT: RNA/DNA EditingRNA base editing

Identifiers

PMID38721279
PMCPMC11077028

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.